VectivBio

VectivBio is owned by Ironwood Pharmaceuticals.

Ironwood Pharmaceuticals is one of the...

• Russell 3000.

Ironwood Pharmaceuticals is a company listed under the stock ticker IRWD (US).

Ironwood Pharmaceuticals has a direct presence in 2 countries.

They are in:

• Pharmaceuticals50%
• Biotechnology50%

Acquisition, funding and merger involving Ironwood Pharmaceuticals.

• Ironwood Pharmaceuticals has announced the acquisition of VectivBio  (posted on May 25 2023).

View the org chart displaying its 17 main executives

Most searched biographies at VectivBio

• Luca Santarelli, Chief Executive Officer and Director
• Hans Schikan, Director
• Wouter Joustra, Director

Create your alert
to follow the executive moves at VectivBio.

Ironwood Pharmaceuticals has 2,275 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Histogen has filed for bankruptcy protection  (posted on April 19 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on April 18 2024).
• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (posted on April 16 2024).

Popular contacts in Biotechnology

• Vik Bajaj - Director at Interline Therapeutics
• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by VectivBio

Social media about VectivBio

• VectivBio on Wikipedia, Google News & Yahoo Finance
• VectivBio on LinkedIn, Twitter & YouTube

Contact by email its executives including Luca Santarelli

Call VectivBio at +41 61...

View the org chart

Register to receive your alert

Report an error